Abstract
The Ewing’s sarcoma family can present diagnostic difficulties. In the past the basis of diagnosis has been a exclusion. Identification of a specific translocation especially t(11; 22) (EWS-FLI 1 fusion gene), which is seen in nearly 85% of Ewing’s sarcoma cases can help in precise diagnosis. We have carried out a study on twenty patient samples diagnosed to have Ewing’s sarcoma/peripheral neuroectodermal tumour (PNET)/small round cell malignant tumour. The study involved RT-PCR analysis for the fusion transcript, followed by sequencing to identify the specific type of fusion. Ninety percent (18/20) of the samples tested were found to be t(11; 22) translocations involving EWS-FLI 1 genes. Sixty-one percent (11/18) were found to be type 1 fusion and seven were type 2 (39%). This is the first study in India with quantitative information about the types of EWS-FLI 1 translocations present in Ewing’s family of tumours in south Indian patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Aurias A, Rimbaut C, Buffe D, Dubousset J and Mazarabad A1983 Chromosomal translocations in Ewing’s sacoma;N. Engl. J. Med. 309 496–497
Barr F G, Qualman S J, Macris M H, Melnick N, Lawler E R, Strzelecki D M, Triche T J, Bridge J A and Sorenson P H 2002 Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusion;Cancer Res. 62 4704–4710
de Alava Eand Gerald W L J 2000 Molecular biology of Ewing’ s sarcoma/primitive neuroectodermal tumor family;Clin. Oncol. 18 204–213
de Alava E, Kawai A, Healey J H, Fligman I, Meyers P A, Huvos A G, Gerald W L, Jhanwar S C, Argani P, Antonescu C R, Pardo-Mindass F J, Ginsberg J, Womer R, Lawlor E R, Wunder J, Andrulis I, Sorensen P H, Barr F G and Ladyani M 1998 EWS-FLI 1 fusion transcript is an independent determinant of prognosis in Ewing’s sarcoma;J. Clin. Oncol. 16 1248–1255
Delattre O, Zucman J, Melot T, Garau X S, Zucker J-M, Lenoir G M, Ambross P F, Sheer D, Turc-Carel C, Triche T J, Aurias A and Thomas G 1994 The Ewing family of tumors — a subgroup of small-round-cell tumors defined by specific chimeric transcripts;New. Engl. J. Med. 331 294–299
Dowing J R, Head D R, Parham D M, Dougalss E C, Hulshof M G, Link M P, Motroni T A, Grier H E and Shapiro D N 1993 Detection of the (11; 22)(q 24; q 12) translocation of Ewing’s’ sarcoma peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction;Am. J. Pathol. 143 1294–1300
Granter S R, Renshaw A A, Fletcher C D, Bhan A K and Rosenberg A E 1996 CD 99 reactivity in mesenchymal chondrosarcoma;Hum. Pathol. 27 1273–1276
Katz R I, Quezado M, Senderowicz A M, Villalba L, Laskin W B and Tsokos M 1997 An intra-abdominal small round cell neoplasm with features of primitive neuroectodermal and desmoplastic round cell tumor and a EWS/FLI-1 fusion transcript;Hum. Pathol. 28 502–509
Levy E R and Herrington C S 1995Non-isotopic methods in molecular biology — A practical approach (IRL Press)
Ladanyi M and Gerald W 1994 Fusion of the EWS and WT1 genes in Desmoplastic small round cell tumor;Cancer Res. 54 2837–2840
McNicol A M and Farquharson M A 1997 In situ hybridization and its diagnostic application in Pathology;J. Pathol. 182 250–261
Naito N, Kawai A, Ouchida M, Dan’ura T, Morimoto Y, Ozaki T, Shimizu K and Inoue H 2000 A reverse transcriptase-polymerase reaction assay in the diagnosis of soft tissue sarcomas;Cancer 89 1992–1998
Peter M, Magdelenet H, Michon J, Melot T, Oberlin O, Zucker J M, Thomas G and Delattre O 1995 Sensitive detection of occult Ewing’s’ cells by reverse transcriptase-polymerase chain reaction;Br. J. Cancer 72 96–100
Pfleiderer C, Zoubek A, Gruber B, Kronberger M, Ambros P F, Lion T, Gander H and Kovari H 1995 Detection of tumor cells in peripheral blood and bone marrow from Ewing’s tumor patients by RT-PCR;Int. J. Cancer 64 135–139
Sorensen P H, Lessnick S L, Lopez-T D, Liu X F, Triche T J and Denny C T 1994 A second Ewing’s sarcoma translocation, t(21, 22) fuses the EWS gene to another ETS family transcription factor, ERG;Nature Genet. 6 146–151
Stevenson A J, Chatten J, Bertoni F and Miettinen M1994 CD 99 (p30/32 MIC 2) neuroectodermal/Ewing’s’ sarcoma antigen as an IHC marker. Review of more than 600 tumors and the literature experience;Appl. Immunohistochem. 2 231–240
Vijayalakshmi N, Selvaluxmi G, Majhi U and Rajkumar T 2002 c-myc oncoprotein expression and prognosis in patients with carcinoma cervix — An immunohistochemical study;Eur. J. Gynaecol. Oncol. 23 135–138
Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christansen H, Niggli F, Gatterer-Menz I, Smith T L, Jurgens H, Gadner H and Kovar H 1996 Expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumour patients?;J. Clin. Oncol. 14 1245–1251
Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker J M, Triche T J, Sheer D and Turc-Carel C 1993 Combinatorial generation of variable fusion proteins in the Ewing’s’ family of tumors;EMBO J. 12 4481–4487
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parija, T., Shirley, S., Uma, S. et al. Type 1 (11; 22)(q24: q12) translocation is common in Ewing’s sarcoma/ peripheral neuroectodermal tumour in south Indian patients. J. Biosci. 30, 371–376 (2005). https://doi.org/10.1007/BF02703674
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02703674